Vyne Therapeutics
formerly VYNEIPORooted in Innovation
Vyne Therapeutics was founded in 2011, is headquartered in Bridgewater, United States, lists 11–50 employees, and has $88.2M in recorded funding across 1 round.
- Headquarters
- Bridgewater, New Jersey
- Employees
- 11–50
- Founded
- 2011
- Business Model
- B2B
- Website
- vynetherapeutics.com
- Total Funding
- $88.2M
- Last Round
- $88.2M Corporate RoundNov 2023
- Rounds
- 1
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
VYNE Therapeutics is a clinical-stage biopharmaceutical company developing therapies for inflammatory and immune-mediated diseases.
Summary
Vyne Therapeutics is a Biotech company based in Bridgewater, United States, founded in 2011. It lists 11–50 employees. It has raised $88.2M in total across 1 round, most recently a $88.2M Corporate Round in Nov 2023. Investors include Access Industries.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Nov 2023
Sign up to see all 2 events
Funding: Corporate Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/vyne-therapeutics"><img src="https://indexed.vc/api/badge/company/vyne-therapeutics" alt="Vyne Therapeutics on Indexed.vc" width="260" height="76" /></a>